Browsing by Subject "Anthracyclines"

Now showing items 1-2 of 2

    • All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic ... 
      Sanz, Miguel A.; Montesinos, Pau; Kim, Haesook T.; Ruiz Argüelles, Guillermo J.; Undurraga, María; Uriarte, María R.; Martínez, Lem; Jacomo, Rafael H.; Gutiérrez Aguirre, Homero; Melo, Raúl; Bittencourt, Rosane; Pasquini, Ricardo; Pagnano, Katia; Fagundes, Evandro M.; Vellenga, Edo; Holowiecka, Alexandra; González Huerta, Ana J.; Fernández, Pascual; Serna, Javier de la; Brunet, Salut; Lisa, Elena de; González Campos, José; Ribera, José M.; Krsnik, Isabel; Ganser, Arnold; Berliner, Nancy; Ribeiro, Raul C.; Lo-Coco, Francesco; Löwenberg, Bob; Rego, Eduardo M. (Springer, 2015)
      Front-line treatment of acute promyelocytic leukaemia (APL) consists of all-trans retinoic acid (ATRA) and anthracycline-based chemotherapy. In this setting, a comparison of idarubicin and daunorubicin has never been carried ...
    • Prevention of doxorubicin-induced cardiotoxicity by pharmacological non-hypoxic myocardial preconditioning ... 
      Carrasco, Rodrigo; Ramírez, María Cristina; Nes, Kjersti; Schuster, Andrés; Aguayo, Rubén; Morales, Marcelo; Ramos, Cristóbal; Hasson, Daniel; Sotomayor, Mario G.; Henríquez, Pablo; Cortés, Ignacio; Erazo Bahamondes, Marcia; Salas, Claudio; Gormaz, Juan G. (BMC, 2020)
      Background Anthracycline-induced cardiotoxicity (AIC), a condition associated with multiple mechanisms of damage, including oxidative stress, has been associated with poor clinical outcomes. Carvedilol, a beta-blocker with ...